Sample preparation for the urinary and serum metabolome
For metabolomic analysis, primary urinary and serum samples were prepared according published procedures [1] .
Urinary proteome analysis

SDS-PAGE processing
The total protein concentration was measured in each sample using a BCA Protein Assay Kit (Thermo Scientific, Waltham, MA, USA) at an absorbance of 570 nm, referenced by standard curve. Urinary proteins were fractionated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS -PAGE).
iTRAQ labelling and 2D-HPLC-MS/MS analysis
Each 200-µg extract sample was prepared following standard digestion, reduction, and alkylation procedures prior to isobaric tag for relative and absolute quantitation (iTRAQ) labelling [3] . Peptide labelling (114-117) with iTRAQ reagent was performed following the manufacturer's protocol. The four isotopic iTRAQ labelling samples were combined and were fractionated on a waters UPLC using a C18 column (waters BEH C18 2.1 ×50mm, 1.7um). Peptides were eluted at a flow rate of 600Μl / min with a linear gradient of 5~35% solvent B (acetonitrile) over 10 min, the solvent A is 20mM ammonium formate with pH adjusted to 10. The absorbance at 214 nm was monitored, and a total of 10 fractions were collected. The fraction was separated by nano-HPLC (Eksigent Technologies) on the secondary RP analytical column (Eksigent, C18, 3µm, 150 mm ×75µm), using a gradient mobile phase 98% acetonitrile -2% milli Q water (A) and 0.1% formic acid (B), at a flow rate of 0.3 µL / min, the gradient program was as follows: 0-5 min: 5% B, 6-65 min: 5-40% B, 65-66 min: 40-80% B, 66-71 min: 80% B, 71-72 min: 80-5% B, and 72-90 min: 5% B. Full scan and tandem mass spectrometry experiments were duplicated again on an AB SCIEX TripleTOF 5600 system. Information-dependent data (IDA) acquisition mode was used to switch automatically between MS and MS/MS acquisition with the following parameters: an ion spray voltage of 2,500 V, curtain gas (CUR) of 25 p.s.i., a cycle time of 1 s, and a dwell time of 30 ms. MS spectra were acquired between 350~1250 m/z (molecular weight/valency) in high-resolution mode (40,000 resolution for full scans and 20,000 resolution for MS/MS scans) with rolling collision energy on via 250-ms accumulation time/spectrum and 50-mDa mass tolerance, and the 10 most intense precursors per cycle were selected for fragmentation with a dynamic exclusion time of 30 s. Data acquisition was conducted using Analyst 2.0 software (AB SCIEX).The collected samples were re-suspended in in 0.1% formic acid solution (0.1% formic acid -2% acetonitrile -98% milli Q water) and analysed on a Eksigent C18 column (150 mm × 75 µm, 3 µm), using a gradient mobile phase 98% acetonitrile-2% milli Q water (A) and 0.1% formic acid (B), at a flow rate of 0.3 µL/min, the gradient program was as follows: 0-5 min: 5% B, 6-65 min: 5-40% B, 65-66 min: 40-80% B, 66-71 min: 80% B, 71-72 min: 80-5% B, and 72-90 min: 5% B.
Urinary proteomic data processing
Original data (*.wiff, *.wiff.scan) acquired from the MS/MS analysis in each LC run were converted to Mascot generic files (*.mgf) using ProteinPilot 4.5 software (AB SCIEX). The MS/MS peak lists of the formatted data were then searched by Mascot (Matrix Science, London, UK; version 2.3.02), spectra were searched against the UniProt database, and the taxonomy was set to Rat. Scaffold (version Scaffold_4.4.5, Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein identifications.
Gene ontology (GO) annotation and network analyses
Protein annotation was subject to GO analysis on the basis of biological responses or disease analysis for biological processes, molecular functions, and cellular components. The differentially expressed proteome (> 1.5-fold changes in all ratios) from the iTRAQ LC-MS/MS analysis of urinary samples was interpreted using Ingenuity Pathway Analysis 9.1 (Ingenuity Systems, Mountain View, CA, USA, www.ingenuity.com) [4] . To conduct a pathway analysis and identify proteins connected to pathways of interest, both upregulated and downregulated proteins were computed in accordance with each network [5, 6] .
We additionally used the hypothesis strategy GeneMANIA (application version 3.6.0, Rattus norvegicus, freely available at http://genemania.org) to generate hypotheses regarding gene function and calculate gene lists and weighting genes, the algorithm of which is designed to automatically weight networks on the basis of levance to the gene set. To evaluate the significance of selected proteins from the observed network, we performed multiple gene queries to identify the most closely connected genes among the networks and attributes selected from IPA enrichment. Physical interactions, pathways, and genetic interactions were generated, and the datasets relevant to ovarian failure and the pro-survival signalling network were collected [7] [8] [9] .
LC-MS MRM for eicosanoid metabolite determination
The LC-MS semi-quantification analysis of eicosanoids was conducted on the AB QTrap 4500 -Agilent 1260 LC-ESI/MS system (AB SCIEX, Agilent Technologies). A 5-µL aliquot of each urine sample was injected onto an Agilent ZORBAX Eclipse Plus C 18 column (100 mm × 4.6 mm, 5 µm; Agilent Technologies) with a mobile phase consisting of 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B). Gradient elution was carried out for 35 min at a flow rate of 0.8 mL/min, and the optimized gradient process was set as follows: 0-25 min: 0.2% -100% B, 25-30 min: 100% B, 30-31 min: 100%-0.2% B, and 31-35 min: 0.2% B. The column temperature was maintained at 30°C. Quantified MS data were obtained with an electrospray ionization (ESI) source in negative ion (NI, 4.5 kV) mode under the following conditions: CUR, 25 p.s.i.; temperatures, 450°C; gas source 1 and gas source 2, 40°C, respectively, referring to the method published by Yan Wang et al. [10] . All data were obtained using Analyst 1.6.2 software (Applied Biosystems), and the metabolites were quantified using Multiquant software (Applied Biosystems) (Supplementary Figure  1 , and Supplementary Table 1 ).
Metabolite biomarker selection and pathway enrichment
To identify biomarkers and construct a metabolite set, a multivariate statistical analysis, including principal component analysis (PCA), partial least squaresdiscriminant analysis (PLS-DA), t-tests, and area under the curve (AUC) analysis, was applied using the MetaboAnalyst 4.0 online platform (available online at http://www.metaboanalyst.ca) [11] . For more consistent and robust biomarker selection and to reduce study biases to facilitate more robust biomarker identification across different experiments on ovarian failure, three batches of data with a sample size capacity of 85 were conducted using the biomarker 'meta-analysis' process on MetaboAnalyst 4.0 [12] . To reveal important links among 'genes, metabolites, and diseases', we next selected the network explorer using the SIMCA-P software (14.1 version) module to represent a comprehensive knowledge base of 'renal lipid metabolism disorder-genesmetabolites' induced by ovarian failure for interactive network visualization [13] .
Phenotypes evaluation
Body weight was monitored weekly, while the organ to body weight ratio (including the liver, kidneys, spleen, uterus, cerebrum, and hypothalamus) were determined at 12 week of the experiment. Biochemical assays were evaluated 12 weeks after rats were OVX. Complete histopathology assays from organs were also performed.
LC-MS scheduled multiple reaction monitoring (MRM) analysis for targeted protein determination
To understand the underlying ovarian failure-driven transformation process in the 'hypothalamus-uteruskidney axis', we performed MRM-based targeted proteomics. Briefly, a representative peptide was chosedchosen for one targeted protein. Heavy isotopelabeled peptides were ordered from BANKPEPTIDE LTD.(Hefei China). Each sample was spiked in heavy isotope-labeled peptide. (the detailed optimization information for each protein is listed in Supplementary Table 2 ) [16, 17] . MRM experiments were performed on a 6500 QTRAP hybrid triple quadrupole/linear ion trap mass spectrometer (AB Sciex, Foster City, CA) interfaced with a Eksigent nano 1D plus system (Waters, Milford, MA). MRM transitions were monitored using unit resolution in both Q1 and Q3 quadrupoles to maximize specificity. Data analyses were performed using SKYLINE (version 2.6).
Targeted protein confirmation by Immunofluorescence (IF), Western blot (WB), real time PCR and Spatial learning behavior test
IF
For double staining with uterus, hypothalamus, and kidney tissues, primary antibody for ERβ (Abcam, ab3576, 1:100), or PTGDS (Abcam, ab182141, 1:3000) was incubated overnight at 4 ºC . After the primary antibodies had been applied, the sections were sequentially incubated with HRP-conjugated secondary antibody (goat anti-rabbit IgG, ab6721, abcam) and CY3-conjugated secondary antibody (goat anti-rabbit IgG, ab6939, abcam). 4',6-diamidino-2phenylindole (DAPI) was used for nuclear staining. The sections were observed under an upright fluorescence microscope (NIKON ECLIPSE C1, Nikon, Japan) connected to a scanning system (NIKON DS-U3, Nikon, Japan) coupled with the digital slide viewer NDP.scan (version 3.2.12, Hamamatsu Photonics, Shizuoka Pref., Japan). Image-Pro plus 6.0 software was used to measure the staining area to obtain the integrated optical density (IOD) and staining area (AREA) values. Then the AOD ratio indicates the ratio of IOD to AREA, that a larger AOD ratio represents a higher protein expression level.
WB
We next confirmed whether the selected anormaly expressed proteins had effect on 'hypothalamus-uteruskidney' axis. The hypothalamus, uterus, and kidneys tissues were removed from control and OVX rats and subjected to western blot analysis. The proteins were transferred onto nitrocellulose membranes. After blocking in 5% BSA-TBST (Sigma), the membranes were incubated with the following primary antibodies from Abcam at 4°C overnight: ERβ (1:1000, ab3576), and Ptgds (1:1000, ab182141). Blots were then washed and incubated with the appropriate secondary antibody for 40 min at room temperature. Blot bands were visualized using chemiluminescence (ECL, WBKLS0500, Millipore). Relative band pixel intensities were semiquantified using ImageJ software (NIH), and protein loading was normalized using an antibody against β-actin (A5441; Sigma-Aldrich) [15] . 
Real time PCR
Spatial learning behavior test (Morris water maze test)
All behavioral testing protocols were approved by the Laboratory Animal Care and Use Committee of the Shaanxi University of Chinese Medicine. The Morris water maze (MWM) test for rats` location and spatial learning was conduct in a 130 cm diameter white plastic maze (130cm diameter ×50cm height) and surrounded by opacity curtains from 9:00-11:00 AM. The maze was filled with opaque water (Titanium powder dyed white, 20~22ºC) and contained a goal (PVC circular escape platform: 10 cm diameter × 22cm height) submerged 1cm below the water surface to keep the rats out of sight.
Location test: After 5 days pretraining procedures, each rat (the head top was dyed in yellow colour) was placed into the water facing the wall on the randomized quadrant points, the timing is stared the moment that the rat is released. When the rat touched the platform and stayed for at least 3s, timing is stopped. Once the rats located the platform, it was allowed to stay for 10 s. Rats not finding the platform within 90s limit are either placed on the platform or guided to it. During each trial, the data of escape latency and swim length were monitored automatically from the digitized image via image tracking system (WMT-100S, Chengdu Technology & Market Corp., LTD, China). AGING Spatial learning test: The spatial learning test was conducted on continuous training day 6 after location test. The invisible platform was removed and the rat was released at a new start position and repeat the trial. During each trial, the data of total number of platform site crossings was monitored.
Statistical analysis
GraphPad Prism 7.0 software (GraphPad Software, La Jolla, CA, USA) was used for the statistical analysis. The statistical analysis for two groups comparisons were conducted using a two-tailed unpaired Student's ttest, for three groups were conducted using one-way ANOVA, followed by Sidak`s multiple comparisons test Differences with p values ˂ 0.05 were considered significant. No statistical methods were used to predetermine the sample size.
